Slide background

Your cells for your treatment: with its family of new generation therapies for hard & soft tissue reconstruction from autologous adipose stem cells
Novadip Biosciences offers a 3D solution without use of scaffold, for better clinical outcomes.

A product family based on a single technology

An innovative family of cell-based regeneration therapies. Novadip Biosciences pioneers the growth of 3-dimensional biologics based on adipose-derived stem cells (ASC), to regenerate hard and soft tissues. ASCs offer sizable advantages in regeneration medicine. The fatty tissue has demonstrated a much higher proportion of stem cells compared to the bone marrow, which is another reservoir

Read More

Our Achievements

Since 2013, Novadip Biosciences has been developing breakthrough innovations in cell-based therapies for hard and soft tissue. While our first mission was to treat patients with bone defects and bone diseases, our adipose stem cell-based technology now offers potential for further applications, including skin regeneration.

Read More

Market Application

Novadip Biosciences: a family of new generation, 3D therapies based on adipose stem cells, for hard and soft tissue reconstruction.   Market application for NVD-001: bone healing disorders and critical size bone defects with unmet medical needs. Bone healing disorders and critical size bone defects following degenerative conditions, trauma, infection, congenital deficiency or tumour resection

Read More

Presentation

Recent News

29Mai2017
NOVADIP appoints Eric Paul Pâques as Chairman of the Board

Mont-Saint-Guibert, Belgium – May 30, 2017 – Advanced biopharmaceutical company NOVADIP BIOSCIENCES, which pioneers the growth of 3-dimensional tissues derived from a

Read More
23Jan2017
Novadip’s looking for a GMP Manufacturing Technician and a QC Scientist !

Please find job descriptions here.

Read More
19Juil2016
Novadip is hiring a QA Assistant

You want to be part of a growing innovative biotech company ? Check out our vacant positions here.

Read More